Nu Skin Enterprises Stock Price Down

Admin   |   10 July, 2015   |   596   |   3980

Nu Skin Enterprises (NYSE:NUS) was down 2.7% on Thursday after an insider sold shares in the company, AnalystRatings.Net reports. The company traded as low as $41.63 and last traded at $42.04, with a volume of 888,258 shares traded. The stock had previously closed at $43.22.

Specifically, insider Daniel R. Chard sold 17,500 shares of Nu Skin Enterprises stock in a transaction that occurred on Monday, July 6th. The shares were sold at an average price of $46.67, for a total transaction of $816,725.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Image source:marketswired.com

Several analysts have recently commented on the stock. Analysts at Citigroup Inc. lowered their price target on shares of Nu Skin Enterprises from $56.00 to $55.00 and set a “buy” rating on the stock in a research note on Thursday. Analysts at Stifel Nicolaus reiterated a “hold” rating on shares of Nu Skin Enterprises in a research note on Sunday, May 10th. Analysts at Canaccord Genuity raised their price target on shares of Nu Skin Enterprises from $56.00 to $60.00 and gave the company a “hold” rating in a research note on Thursday, May 7th. Finally, analysts at Zacks downgraded shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Monday, May 4th. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $58.25.

The stock’s 50-day moving average is $49.41 and its 200-day moving average is $51.81. The company has a market cap of $2.45 billion and a price-to-earnings ratio of 14.88.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.72 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.73 by $0.01. The company had revenue of $543.30 million for the quarter, compared to the consensus estimate of $544.70 million. During the same quarter in the prior year, the company posted $1.05 earnings per share. The company’s quarterly revenue was down 20.4% on a year-over-year basis. Analysts expect that Nu Skin Enterprises will post $3.71 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 10th. Investors of record on Friday, May 22nd were given a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a yield of 3.35%. The ex-dividend date of this dividend was Wednesday, May 20th.

Nu Skin Enterprises, Inc. is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively. The Company introduced Pharmanex nutritional supplements and Nu Skin personal care products under its age LOC anti-aging brand. The Company offers anti-aging personal care products. Products in this category include its ageLOC Galvanic Spa System, its ageLOC Galvanic Body Spa, ageLOC Galvanic Spa Body Shaping Gel and ageLOC Dermatic Effects Body Contouring Lotion and its ageLOC Transformation anti-aging skin care system. The Company markets a variety of products under its Pharmanex brand. LifePak, its line of micronutrient supplements. Other anti-aging nutritional supplements include its ageLOC R2, which is designed to renew and recharge the body.

Fore more news about Nu skin click here